Gland Pharma shares rally nearly 8 pc; at 52-week high after Q1 earnings

By: |
July 22, 2021 1:54 PM

Drug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter ended June 30, 2021, on account of robust sales in all markets.

Pharma sectorThe Indian pharmaceutical industry worked continuously during the testing times of COVID-19 pandemic second wave to ensure the availability of life saving medicines.

Shares of Gland Pharma on Thursday jumped nearly 8 per cent after the company reported an 11.83 per cent increase in its consolidated net profit for the quarter ended June 30, 2021. It zoomed 7.50 per cent to Rs 4,087.65 — its 52-week high — at the BSE.

On the NSE, it rallied 7.75 per cent to its 52-week high of Rs 4,089. Drug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter ended June 30, 2021, on account of robust sales in all markets. The company had posted a net profit of Rs 313.6 crore for the corresponding period of the previous fiscal, Gland Pharma said in a regulatory filing.

Consolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore for the same period a year ago, it added. “In spite of the challenges from the second wave of COVID in the country, in terms of manpower availability and supply chain bottlenecks, Gland Pharma has managed to deliver strong quarterly results,” Gland Pharma Managing Director and Chief Executive Officer Srinivas Sadu said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Fino Payments Bank files Rs 1,300-cr IPO papers with Sebi
2Buy these 2 stocks with support on charts; Nifty’s consolidation may end soon
3India’s AIF industry witnesses robust growth despite pandemic and it could just be the beginning